Vedere Bio II Appoints Accomplished Clinician and Researcher Anna-Maria Demetriades as Chief Medical Officer

CAMBRIDGE, Mass., April 26, 2022 /PRNewswire/ -- Vedere Bio II, Inc., a company developing transformative, next-generation therapies for vision re...

Related Keywords

Miami ,Florida ,United States ,Japan ,Cambridge ,Cambridgeshire ,United Kingdom ,Anna Maria Demetriades ,Cyrus Mozayeni ,Prnewswire Vedere Bio Ii Inc ,Glaucoma Service At Weill Cornell Medicine ,Linkedin ,Genentech ,Twitter ,Bascom Palmer Eye Institute ,Wilmer Eye Institute ,Vedere Bio Ii Inc ,University Of Oxford ,Physiological Sciences ,Mission Biocapital ,University Of Miami Miller School Medicine ,Access Consortium ,Roche Group ,Rd Fund ,Chief Medical ,Chief Executive Officer ,Vedere Bio ,Atlas Venture Entrepreneur ,Glaucoma Service ,Weill Cornell Medicine ,New York Presbyterian Hospital ,Assistant Professor ,Johns Hopkins Hospital ,Miami Miller School ,Atlas Ventures ,Octagon Capital ,Samsara Biocapital ,